| scholarly article | Q13442814 |
| P50 | author | Karl-Heinz Wagner | Q38362708 |
| Leo E Otterbein | Q57032230 | ||
| Barbara Wegiel | Q77368594 | ||
| P2093 | author name string | Andrew C Bulmer | |
| Oliver Neubauer | |||
| Kavita Bisht | |||
| Jens Tampe | |||
| P2860 | cites work | Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes | Q24534395 |
| NF-kappaB activation and inhibition: a review | Q28217099 | ||
| Upstream and downstream of mTOR | Q28277365 | ||
| The complement system | Q34137841 | ||
| New insights of an old defense system: structure, function, and clinical relevance of the complement system | Q34699496 | ||
| Effects of biliverdin administration on acute lung injury induced by hemorrhagic shock and resuscitation in rats | Q34718303 | ||
| Biliverdin inhibits Toll-like receptor-4 (TLR4) expression through nitric oxide-dependent nuclear translocation of biliverdin reductase | Q35558775 | ||
| Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration | Q35636116 | ||
| Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo | Q35850677 | ||
| Functional role for toll-like receptors in atherosclerosis and arterial remodeling | Q35884631 | ||
| Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome | Q36041536 | ||
| Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt. | Q37372039 | ||
| Complement activation and disease: protective effects of hyperbilirubinaemia | Q37609484 | ||
| Potential application of biliverdin reductase and its fragments to modulate insulin/IGF-1/MAPK/PI3-K signaling pathways in therapeutic settings | Q37779560 | ||
| Go green: the anti-inflammatory effects of biliverdin reductase | Q37996018 | ||
| Exploring the specificity of the PI3K family inhibitor LY294002. | Q40170788 | ||
| Effects of bilirubin on neutrophil responses in newborn infants. | Q40289042 | ||
| Andrographolide acts through inhibition of ERK1/2 and Akt phosphorylation to suppress chemotactic migration | Q40516272 | ||
| The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells | Q40726959 | ||
| Tumor necrosis factor-alpha mRNA remains unstable and hypoadenylated upon stimulation of macrophages by lipopolysaccharides | Q40853644 | ||
| Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages | Q42088673 | ||
| C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway | Q43889524 | ||
| Inflammatory responses induced by lipopolysaccharide are amplified in primary human monocytes but suppressed in macrophages by complement protein C5a. | Q44641990 | ||
| Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts | Q44772668 | ||
| Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome. | Q46036068 | ||
| The TSC-mTOR signaling pathway regulates the innate inflammatory response | Q46321173 | ||
| Biliverdin administration protects against endotoxin-induced acute lung injury in rats | Q46697021 | ||
| Complement takes its Toll: an inflammatory crosstalk between Toll-like receptors and the receptors for the complement anaphylatoxin C5a. | Q48206428 | ||
| In vitro antioxidant capacity and antigenotoxic properties of protoporphyrin and structurally related tetrapyrroles | Q50025304 | ||
| Complement C5a inhibition reduces atherosclerosis in ApoE-/- mice. | Q54378056 | ||
| Processing of tumour necrosis factor-α precursor by metalloproteinases | Q59059630 | ||
| Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin | Q64375853 | ||
| C5a receptor and thymocyte apoptosis in sepsis | Q74211259 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endotoxins | Q319997 |
| P304 | page(s) | 94-99 | |
| P577 | publication date | 2014-05-09 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Biliverdin modulates the expression of C5aR in response to endotoxin in part via mTOR signaling | |
| P478 | volume | 449 |
| Q90625004 | Bilirubin Safeguards Cardiorenal and Metabolic Diseases: a Protective Role in Health |
| Q28071435 | Bilirubin in coronary artery disease: Cytotoxic or protective? |
| Q39080342 | Biological signaling by carbon monoxide and carbon monoxide-releasing molecules |
| Q63916924 | Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a--C5aR1 Pathway |
| Q34093709 | Endogenous Tetrapyrroles Influence Leukocyte Responses to Lipopolysaccharide in Human Blood: Pre-Clinical Evidence Demonstrating the Anti-Inflammatory Potential of Biliverdin. |
| Q92510535 | Heme Catabolic Pathway in Inflammation and Immune Disorders |
| Q61443683 | Heme detoxification by heme oxygenase-1 reinstates proliferative and immune balances upon genotoxic tissue injury |
| Q48578792 | Heme oxygenase-1 is a potent inhibitor of placental ischemia-mediated endothelin-1 production in cultured human glomerular endothelial cells |
| Q89820673 | Heme-Derived Metabolic Signals Dictate Immune Responses |
| Q49588930 | Immune challenges decrease biliverdin concentration in the spleen of northern Bobwhite quail, Colinus virginianus |
| Q37693865 | Inducible Nitric Oxide Synthase (iNOS) Is a Novel Negative Regulator of Hematopoietic Stem/Progenitor Cell Trafficking. |
| Q41774347 | Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation |
| Q91433898 | Modulation of the monocyte/macrophage system in heart failure by targeting heme oxygenase-1 |
| Q91896679 | Protective Role of mTOR in Liver Ischemia/Reperfusion Injury: Involvement of Inflammation and Autophagy |
| Q27715540 | Rv2074 is a novel F420 H2 -dependent biliverdin reductase in Mycobacterium tuberculosis |
| Q99708873 | The Role of Bilirubin and the Other "Yellow Players" in Neurodegenerative Diseases |
Search more.